Clinical trial

Neurocognitive Performance During Hyperglycemia , and Brain Tissue Integrity in Youth With Type 1 Diabetes and in Healthy

NCT02923323

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention MRI including DTI , EEG, CGMS Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Neurocognitive tests Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Neurocognitive Performance During Hyperglycemia , and Brain Tissue Integrity in Youth With Type 1 Diabetes and in Healthy

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2016-03-01

PhaseNA

Conditions

Diabetes Mellitus, Type 1unresolved

Interventions

MRI including DTI , EEG, CGMSDEVICE

Neurocognitive testsBEHAVIORAL

Sponsors & collaborators

Assaf-Harofeh Medical Centerlead sponsor

Bar-Ilan University, Israelcollaborator

Hadassah Medical Organizationcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02923323 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.